Wall Street brokerages expect Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) to announce sales of $4.56 million for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Syros Pharmaceuticals’ earnings. The lowest sales estimate is $3.10 million and the highest is $5.85 million. Syros Pharmaceuticals reported sales of $4.83 million in the […]
$5 65 Million in Sales Expected for Syros Pharmaceuticals, Inc (NASDAQ:SYRS) This Quarter etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.